3rd Quarter - Report

INVITROGEN CORPORATION for INVITROGEN CORPORATION

Period 3rd Quarter 2008 Filed Oct 19, 2008 Signed by JASON D. KAUNE, ATTORNEY & AGENT FOR FILER

Official filing
Firm
INVITROGEN CORPORATION
Client
INVITROGEN CORPORATION
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR6498/S976: GENOMICS AND PERSONALIZED MEDICINE ACT OF 2008; ALL PROVISIONS

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6498 (110th)

Budget/Appropriations BUD

S3230: DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS ACT, 2009; NATIONAL INSTITUTES OF HEALTH & BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY FUNDING HR2638: CONSOLIDATED SECURITY, DISASTER ASSISTANCE, AND CONTINUING APPROPRIATIONS ACT, 2009; BIOMEDICAL RESEARCH FUNDING (NATIONAL INSTITUTES OF HEALTH AND BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY), DEPARTMENTS OF LABOR, HEALTH & HUMAN SERVICES FUNDING AND DEPARTMENT OF DEFENSE APPROPRIATIONS (BIO-DEFENSE FUNDING)

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2638 (110th)

Financial Institutions/Investments/Securities FIN

HR1424: EMERGENCY ECONOMIC STABILIZATION ACT OF 2008; CREDIT MARKET STABILITY

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1424 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.